lisata therapeutics (1)

The Journey of Lisata Therapeutics, Inc., Validating the Successful Merger of Cend Therapeutics & Caladrius Biosciences

Caladrius Biosciences and Cend Therapeutics merged, creating Lisata Therapeutics, Inc. at the start of 2022. The company was initially incepted in 1980 as Corniche Group Inc., Phase III Medical Inc.,[4] and NeoStem, Inc., and in 2015, the company cha...

Patrick John · 17 January · 3